Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: R01HL122347,T32GM007347
NCI NIH HHS
Grant: P30 CA068485
NIGMS NIH HHS
Grant: T32 GM007347
NIDDK NIH HHS
Grant: U24 DK059637
National Science Foundation
Grant: STTR 1622828
NHLBI NIH HHS
Grant: R01 HL122347
NIGMS NIH HHS
Grant: T32 GM152284
NIH HHS
Grant: S10 OD023475
National Institutes of Health
Grant: 5R01HL122347-04
MK2 Inhibitory Nanoplexes to Enhance Long-Term Vascular Graft Patency
National Institutes of Health
Grant: 1S10OD023475-01A1
Leica Bond RX
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Institutes of Health
Grant: 1U24DK059637-01
CORE--METABOLIC PATHOPHYSIOLOGY
National Institutes of Health
Grant: 5T32GM007347-08
MEDICAL SCIENTIST TRAINING PROGRAM
FWCI
2.19
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals